Pregabalin In Addition To Usual Care For Sciatica (PRECISE): A Randomised, Placebo-controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$638,663.00
Summary
Sciatica is a severe and disabling form of back pain that is characterised by radiating pain down the leg. However there is little evidence on how best to treat it conservatively. We propose to investigate the effectiveness of pregabalin, a medication that specifically targets sciatic pain, in addition to usual care in 204 patients with sciatica. We hypothesise that adding pregabalin will be more effective in reducing the severity of leg pain.
Acupuncture To Improve Live Birth Rates For Women Undergoing IVF: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$636,285.00
Summary
We will undertake a randomised controlled of acupuncture as an adjunct to IVF treatment. Acupuncture will be compared to a placebo group and standard care group to examine the clinical effect on live births. We will also examine if the cost effectiveness of IVF can be improved with acupuncture. We will undertake in-depth interviews with the participants to understand the personal and social context of acupuncture, illuminate reasons why the acupuncture may or may not have worked, and identify ot ....We will undertake a randomised controlled of acupuncture as an adjunct to IVF treatment. Acupuncture will be compared to a placebo group and standard care group to examine the clinical effect on live births. We will also examine if the cost effectiveness of IVF can be improved with acupuncture. We will undertake in-depth interviews with the participants to understand the personal and social context of acupuncture, illuminate reasons why the acupuncture may or may not have worked, and identify other effects of acupuncture.Read moreRead less
AusGo-SHEMO….Let’s Go! Australian Gold Standard Health Economics Model Of Osteoporosis
Funder
National Health and Medical Research Council
Funding Amount
$378,959.00
Summary
We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screening and treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may be squandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse, patient access to cost-effective medications may be delayed.
Evaluation Of Alcohol Management Plans (AMPs), Cape York, North Queensland
Funder
National Health and Medical Research Council
Funding Amount
$626,395.00
Summary
The study will describe long-term impacts on important health and social outcomes of restricting alcohol in Cape York, Queensland. It will assess the impacts and cost-effectiveness of the Queensland Government’s Alcohol Management Plans implemented from 2002-03. The researchers will use de-identified data on injury, violence, health and social indicators. The study will map whether AMP components were delivered as promised and the extent to which they were welcomed by Cape York communities.
Cost-effective Development And Validation Of Risk Prediction Models: Methods And Applications
Funder
National Health and Medical Research Council
Funding Amount
$157,322.00
Summary
We will develop statistical methods and software that will enable risk calculators being built and validated using study designs that require only a fraction of current cost. The methods and software will be freely-available to researchers worldwide.
Rapidly giving intravenous fluid to prevent or treat shock (fluid resuscitation) is one of the commonest treatments given to critically ill patients. Current guidelines recommend crystalloid solutions but it is unknown whether any particular crystalloid is better than others. This trial will determine whether the use of one of two crystalloid fluids, saline or PlasmaLyte, reduces the risk of organ injuries, such as kidney failure, and improves patients chances of surviving critically illness.
Modelling The Cost-effectiveness Of Therapeutic Strategies For Invasive Candidiasis Among The ICU Population
Funder
National Health and Medical Research Council
Funding Amount
$282,733.00
Summary
ICU patients are vulnerable to fungal infections during their stay in hospital. These infections are costly to treat and pose real dangers to the patient with up to 1270 lives lost each year. The best way to diagnose and treat these infections is currently not known. Making an early and accurate diagnosis is difficult but important if the infection is to be managed appropriately. This research will show which management strategies are optimal for patients and health services.
Optimising Upper Limb Recovery Following Stroke: A Randomised Controlled Trial Of The Effects Of Botulinum Toxin-A Combined With Intensive Rehabilitation Compared To Botulinum Toxin-A Alone
Funder
National Health and Medical Research Council
Funding Amount
$1,070,230.00
Summary
The devastating loss of movement in the hand after stroke could potentially be addressed, but we currently lack of research investigating treatment interventions. This randomised controlled trial will compare the routine interventions of botulinum toxin to botulinum toxin plus best-practice therapy for both cost and clinical outcome. Findings from this trial will provide the necessary information to make decisions about what will improve spasticity and function in the hand and arm after stroke.
AVERT-DOSE (Determining Optimal Early Rehabilitation After StrokE): A Multi-arm Covariate-adjusted, Response-adaptive Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$4,359,564.00
Summary
AVERT-DOSE is an international, investigator-led clinical trial, developed in Australia but recruiting >2500 patients from 6 countries around the world. In this trial we will establish the optimal model of early mobility rehabilitation for people with acute stroke. The protocols we develop will be suitable for adoption in clinical practice in developed and developing countries and help reduce the unacceptably high personal and community burden of stroke-related disability world wide.
Effectiveness, Cost-effectiveness And Cost-benefit Of A Single Annual Professional Intervention For The Prevention Of Childhood Dental Caries In A Remote Rural Indigenous Community
Funder
National Health and Medical Research Council
Funding Amount
$1,050,869.00
Summary
The aim of the study is to reduce the high prevalence of tooth decay in children in a remote, rural Indigenous community, by application of a single annual dental preventive intervention. Most dental preventive interventions require regular re-application (3 monthly), which is not possible in resource constrained communities. Importantly, the study will assess cost-benefit and cost-effectiveness for broader implementation across similar communities in Australia and internationally.